Authors: DRAYSON MT CHAPMAN CE DUNN JA OLUJOHUNGBE AB MACLENNAN ICM

Citation: Mt. Drayson et al., MRC TRIAL OF INTERFERON-ALPHA-2B MAINTENANCE THERAPY IN FIRST PLATEAU-PHASE OF MULTIPLE-MYELOMA, British Journal of Haematology, 101(1), 1998, pp. 195-202

Authors: DRAYSON MT DUNN JA OLUJOHUNGBE AB MACLENNAN ICM

Citation: Mt. Drayson et al., INTERFERON-ALPHA-2B TREATMENT USED IN PLATEAU-PHASE OF MULTIPLE-MYELOMA INCREASES RELAPSE-FREE INTERVAL BUT NOT OVERALL SURVIVAL, British Journal of Haematology, 93, 1996, pp. 208-208

Authors: OLUJOHUNGBE AB DUNN JA DRAYSON MT MACLENNAN ICM

Citation: Ab. Olujohungbe et al., PREDNISOLONE ADDED TO THE ABCM AS TREATMENT FOR MULTIPLE-MYELOMA INCREASES SEROLOGICAL RESPONSES BUT NOT OVERALL SURVIVAL OR THE NUMBER OF STABLE CLINICAL-RESPONSES, British Journal of Haematology, 93, 1996, pp. 296-296

Authors: DRAYSON MT DUNN JA OLUJOHUNGBE AB MACLENNAN ICM

Citation: Mt. Drayson et al., INTERFERON-ALPHA-2B TREATMENT USED IN PLATEAU-PHASE OF MULTIPLE-MYELOMA INCREASES RELAPSE-FREE INTERVAL BUT NOT OVERALL SURVIVAL, Blood, 88(10), 1996, pp. 2332-2332